89Zr-PSMA-617 PET/CT May Reveal Local Recurrence of Prostate Cancer Unidentified by 68Ga-PSMA-11 PET/CT

Florian Rosar; Mark Bartholomä; Stephan Maus; Bastiaan M Privé; Fadi Khreish; Gerben M Franssen; Yvonne H W Derks; James Nagarajah; Samer Ezziddin

doi:10.1097/RLU.0000000000004108

⁸⁹Zr-PSMA-617 PET/CT May Reveal Local Recurrence of Prostate Cancer Unidentified by ⁶⁸Ga-PSMA-11 PET/CT

Florian Rosar, Mark Bartholomä, Stephan Maus, Bastiaan M Privé, Fadi Khreish, Gerben M Franssen, Yvonne H W Derks, James Nagarajah, Samer Ezziddin^*

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

12 Citations (Scopus)

Abstract

For localization of biochemical recurrence of prostate cancer, ⁶⁸Ga-PSMA-11 PET/CT imaging was performed in a 66-year-old man with no suspicious findings at 1 hour p.i. Additional ⁸⁹Zr-PSMA-617 PET/CT revealed a small local recurrence in the prostate bed, facilitating consecutive local therapy. This interesting image points to the potential of PET/CT with ⁸⁹Zr-labeled PSMA ligands, for example, ⁸⁹Zr-PSMA-617, for identifying the source of biochemical recurrence despite otherwise negative imaging including conventional PSMA PET/CT.

Original language	English
Pages (from-to)	435-436
Number of pages	2
Journal	Clinical Nuclear Medicine
Volume	47
Issue number	5
DOIs	https://doi.org/10.1097/RLU.0000000000004108
Publication status	Published - May 2022
Externally published	Yes

Bibliographical note

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/RLU.0000000000004108

Cite this

@article{3f04d1d15b874c3d918c4ccb173607a8,

title = "89Zr-PSMA-617 PET/CT May Reveal Local Recurrence of Prostate Cancer Unidentified by 68Ga-PSMA-11 PET/CT",

abstract = "For localization of biochemical recurrence of prostate cancer, 68Ga-PSMA-11 PET/CT imaging was performed in a 66-year-old man with no suspicious findings at 1 hour p.i. Additional 89Zr-PSMA-617 PET/CT revealed a small local recurrence in the prostate bed, facilitating consecutive local therapy. This interesting image points to the potential of PET/CT with 89Zr-labeled PSMA ligands, for example, 89Zr-PSMA-617, for identifying the source of biochemical recurrence despite otherwise negative imaging including conventional PSMA PET/CT.",

author = "Florian Rosar and Mark Bartholom{\"a} and Stephan Maus and Priv{\'e}, {Bastiaan M} and Fadi Khreish and Franssen, {Gerben M} and Derks, {Yvonne H W} and James Nagarajah and Samer Ezziddin",

year = "2022",

month = may,

doi = "10.1097/RLU.0000000000004108",

language = "English",

volume = "47",

pages = "435--436",

journal = "Clinical Nuclear Medicine",

issn = "0363-9762",

publisher = "Lippincott Williams & Wilkins",

number = "5",

}

TY - JOUR

T1 - 89Zr-PSMA-617 PET/CT May Reveal Local Recurrence of Prostate Cancer Unidentified by 68Ga-PSMA-11 PET/CT

AU - Rosar, Florian

AU - Bartholomä, Mark

AU - Maus, Stephan

AU - Privé, Bastiaan M

AU - Khreish, Fadi

AU - Franssen, Gerben M

AU - Derks, Yvonne H W

AU - Nagarajah, James

AU - Ezziddin, Samer

PY - 2022/5

Y1 - 2022/5

N2 - For localization of biochemical recurrence of prostate cancer, 68Ga-PSMA-11 PET/CT imaging was performed in a 66-year-old man with no suspicious findings at 1 hour p.i. Additional 89Zr-PSMA-617 PET/CT revealed a small local recurrence in the prostate bed, facilitating consecutive local therapy. This interesting image points to the potential of PET/CT with 89Zr-labeled PSMA ligands, for example, 89Zr-PSMA-617, for identifying the source of biochemical recurrence despite otherwise negative imaging including conventional PSMA PET/CT.

AB - For localization of biochemical recurrence of prostate cancer, 68Ga-PSMA-11 PET/CT imaging was performed in a 66-year-old man with no suspicious findings at 1 hour p.i. Additional 89Zr-PSMA-617 PET/CT revealed a small local recurrence in the prostate bed, facilitating consecutive local therapy. This interesting image points to the potential of PET/CT with 89Zr-labeled PSMA ligands, for example, 89Zr-PSMA-617, for identifying the source of biochemical recurrence despite otherwise negative imaging including conventional PSMA PET/CT.

UR - http://www.scopus.com/inward/record.url?scp=85128245395&partnerID=8YFLogxK

U2 - 10.1097/RLU.0000000000004108

DO - 10.1097/RLU.0000000000004108

M3 - Editorial

C2 - 35234197

SN - 0363-9762

VL - 47

SP - 435

EP - 436

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

IS - 5

ER -